Neurology Advisor | Practice Changing News for Clinicians

Pfizer COVID-19 Vaccine: 92.6% Efficacy After First Dose

New data about Pfizer COVID-19 efficacy after the first dose suggests high efficacy, raising questions about potential alternative dosing schedules.
Controversy: Protecting People Who Use Drugs During COVID-19

Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
Urinary Tract Infections and Multiple Sclerosis

Amit Akirov, MD, discusses the risk, prevalence, diagnosis, and management of urinary tract infections among patients with multiple sclerosis.
But Is it Fair? Bioethics, COVID-19 Vaccine Distribution, Advocacy

We speak with Mildred Solomon, EdD, President of the Hastings Center and Professor of Global Health and Social Medicine at Harvard Medical School, where she directs the school’s Fellowship in Bioethics, about the COVID-19 pandemic, health equity, and vaccine distribution.
Caring for Patients With DMD During COVID-19 Pandemic

Tori Rodriguez, MA, LPC, discusses the progression of care for patients with Duchenne muscular dystrophy during the COVID-19 pandemic.

more features»

Weekly Rounds Podcast

How are researchers working to build a better test for COVID-19? What can clinicians in the US accomplish with point of care testing? Find out on Weekly Rounds.

Featured guest is David Alland, MD, MSc, Professor of Medicine and the Chief of Infectious Disease at Rutgers New Jersey Medical School.

Subscribe for more episodes:
Apple Podcasts | Google Podcasts | Spotify | RSS feed